MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Intrexon Corp Company Profile (NYSE:XON)

Consensus Ratings for Intrexon Corp (NYSE:XON) (?)
Ratings Breakdown: 3 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $52.63 (119.27% upside)

Analysts' Ratings History for Intrexon Corp (NYSE:XON)
Show:
DateFirmActionRatingPrice TargetActions
6/7/2016Griffin SecuritiesReiterated RatingBuy$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016JMP SecuritiesInitiated CoverageOutperform$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2016Stifel NicolausReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2016Bank of AmericaReiterated RatingNeutral$41.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016MizuhoReiterated RatingNeutral$28.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2016WunderlichReiterated RatingBuy$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015Merriman CapitalUpgradeNeutral -> Buy$85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015JPMorgan Chase & Co.DowngradeOverweight -> Neutral$45.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for Intrexon Corp (NYSE:XON)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/10/2016Q1($0.20)($0.55)$46.26 million$43.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/29/2016Q415($0.18)($0.28)$41.82 million$41.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q3($0.21)($0.34)$40.84 million$53.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.04)$0.01$55.93 million$44.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q115($0.12)$0.25$32.90 million$33.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/2/2015Q414($0.16)$0.18$26.11 million$31.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/13/2014Q314($0.16)($0.53)$19.40 million$21.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/14/2014Q214($0.13)($0.11)$9.39 million$11.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q1$0.06$0.04$11.25 million$7.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/31/2014Q413($0.14)($0.13)$8.38 million$7.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013($0.03)$0.15$9.79 million$6.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Intrexon Corp (NYSE:XON)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.22)($0.21)($0.22)
Q2 20162($0.22)($0.21)($0.22)
Q3 20162($0.33)($0.22)($0.28)
Q4 20162($0.28)($0.18)($0.23)
(Data provided by Zacks Investment Research)
Dividend History for Intrexon Corp (NYSE:XON)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Intrexon Corp (NYSE:XON)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/13/2016Randal J KirkCEOBuy41,830$23.92$1,000,573.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015Randal J KirkCEOBuy124,475$29.85$3,715,578.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2015Randal J KirkCEOBuy237,525$30.69$7,289,642.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2015Suma KrishnanSVPSell20,900$35.66$745,294.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/27/2015Randal J KirkCEOBuy555,556$27.00$15,000,012.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014Donald LehrInsiderBuy1,850$15.99$29,581.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014Randal KirkCEOBuy65,173$15.19$989,977.87View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2014Kelly HuangSVPBuy3,200$15.78$50,496.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2014Krish KrishnanCOOBuy20,900$14.21$296,989.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/27/2014Randal KirkCEOBuy243,001$25.72$6,249,985.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2014Gregory Ian FrostSVPBuy100,000$25.95$2,595,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2013Jeffrey B KindlerDirectorBuy33,000$16.00$528,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2013Randal J KirkCEOBuy1,887,500$16.00$30,200,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2013Thomas D ReedInsiderBuy1,800$16.00$28,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2013Thomas R KasserSVPBuy5,000$16.00$80,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Intrexon Corp (NYSE:XON)
DateHeadline
06/25/16 06:37 PMAre Analysts Bearish Intrexon Corp (NYSE:XON) After Last Week? - Engelwood Daily
06/25/16 10:59 AMPomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intrexon Corporation of Class Action Lawsuit and Upcoming Deadline – XON
06/25/16 10:59 AMAnalyst’s Keeping an Eye on Intrexon Corp (NYSE:XON)
06/24/16 07:21 PMLmm LLC Increased Intrexon Corp (NYSE:XON) by $5.85 Million as Shares Rose - Engelwood Daily
06/24/16 02:36 PMSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intrexon Corporation of Class Action Lawsuit and Upcoming Deadline – XON - [GlobeNewswire] - NEW YORK, June 24, 2016-- Pomerantz LLP announces that a class action lawsuit has been filed against Intrexon Corporation and certain of its officers. The class action, filed in United States District ...
06/23/16 08:11 PMInvestor News: Investigation of potential Wrongdoing at Intrexon Corp (NYSE:XON)
06/23/16 05:44 PMINTREXON DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Intrexon Corporation And Reminds Shareholders With Losses In Excess of $100,000 To Contact The Firm - [Accesswire] - LOS ANGELES, CA / ACCESSWIRE / June 23, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company") (NYSE: XON) concerning ...
06/22/16 05:52 PMFINAL NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Intrexon Corporation And Advises Investors With Losses To Contact The Firm - [Accesswire] - LOS ANGELES, CA / ACCESSWIRE / June 22, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company") (NYSE: XON) concerning ...
06/22/16 04:30 PMBragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Intrexon Corporation (XON) and Encourages Investors to Contact the Firm - [Business Wire] - Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who acquired Intrexon Corporation securities between May 12, 2015 and April 20, 2016 .
06/22/16 04:29 AMIntrexon Corp (NYSE:XON) & Inovio Pharmaceuticals (NASDAQ:INO) Healthcare Stocks Under Consideration - Wall Street 24
06/20/16 06:50 PMSterling in biggest one-day gain since 2008 as Brexit fears ease
06/20/16 10:55 AMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Intrexon Corporation of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 5, 2016 – XON - [GlobeNewswire] - NEW YORK, June 20, 2016-- The following statement is being issued by Levi & Korsinsky, LLP:. To: All persons or entities who purchased or otherwise acquired securities of Intrexon Corporation between May ...
06/20/16 08:42 AMHC Stocks Broker Alerts: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Intrexon Corp (NYSE:XON) - share market updates (press release)
06/20/16 07:00 AMIntrexon to Present at the JMP Securities Life Sciences Conference - [PR Newswire] - GERMANTOWN, Md., June 20, 2016 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announces Geno Germano, President of Intrexon, will present at the JMP Securities Life Sciences ...
06/17/16 09:07 PMINTREXON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Intrexon Corporation - XON - [PR Newswire] - NEW ORLEANS, June 17, 2016 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until ...
06/17/16 11:48 AMDEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Intrexon Corporation (XON) and Lead Plaintiff Deadline: July 5, 2016 - [Accesswire] - NEW YORK / ACCESSWIRE / June 17, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against Intrexon Corporation ("Intrexon" or "the Company") (NYSE: XON). ...
06/17/16 10:04 AMThe Insider Activity Don’t Lie: Intrexon Corporation (NYSE:XON)
06/16/16 07:33 PMIntrexon (XON) Weak On High Volume - TheStreet.com
06/16/16 09:54 AMBetter Buy: Intrexon Corporation vs. Inovio Pharmaceuticals Inc. - Two biotechs fighting the Zika virus in radically different ways. Which deserves to win the battle for investors' favor?
06/15/16 07:13 PMIntrexon (XON) Strong On High Relative Volume Today - TheStreet.com
06/15/16 08:53 AMINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Intrexon Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 5, 2016 - [Business Wire] - The following statement is being issued by Levi & Korsinsky, LLP:
06/15/16 07:30 AMExemplar Genetics to Present on Novel Research Models for Oncology at the World Preclinical Congress - [PR Newswire] - SIOUX CENTER, Iowa, June 15, 2016 /PRNewswire/ -- Exemplar Genetics announced its President, John Swart, Ph.D., will present today at the 15th Annual World Preclinical Congress during the Preclinical Models ...
06/15/16 04:27 AMAnalyst Price Target Update on Intrexon Corporation (NYSE:XON) - TheFounders Daily
06/13/16 03:35 PMINTREXON CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Secur -
06/13/16 10:18 AMFibrocell to focus on gene therapy portfolio of drug candidates
06/13/16 10:18 AMIntrexon : Assigned Patent
06/13/16 08:27 AMIntrexon Battles Thermodynamics, but Thermodynamics Always Wins -
06/13/16 07:29 AMFibrocell Announces Initiation of Patient Recruitment in Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa - [at noodls] - EXTON, Pa., June 13, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), an autologous cell and gene therapy company translating personalized biologics into medical breakthroughs for diseases ...
06/11/16 07:36 PMFormer NCI Director Broder to Retire from Intrexon - The Cancer Letter Publications
06/11/16 07:36 PMIntrexon Corporation (XON) Drops 5.17% on June 09 - Equities.com
06/11/16 07:36 PMToday's Dead Cat Bounce Stock Is Intrexon (XON) - TheStreet.com
06/11/16 10:19 AMFormer NCI Director Broder to Retire from Intrexon
06/11/16 10:19 AMTop Earnings to Watch for: Intrexon Corporation (NYSE:XON)
06/10/16 01:06 PMINTREXON SHAREHOLDER ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Intrexon Corporation and Encourages Investors with Losses to Contact the Firm - [Accesswire] - IRVINE, CA / ACCESSWIRE / June 10, 2016 / Khang & Khang LLP (the "Firm") announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company") ...
06/10/16 12:55 PMGlancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Intrexon Corporation Investors and Encourages Investors to Contact the Firm - [Business Wire] - Glancy Prongay & Murray LLP announces that a class action lawsuit has been filed on behalf of investors who purchased Intrexon Corporation securities between May 12, 2015 and April 20, 2016, inclusive .
06/10/16 12:19 PMEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Intrexon Corporation - XON - [GlobeNewswire] - NEW YORK, June 10, 2016-- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Intrexon Corporation securities from May 12, 2015 ...
06/10/16 11:14 AMSHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Intrexon Corporation and a Lead Plaintiff Deadline of July 5, 2016 - XON - [Business Wire] - The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Intrexon Corporation securities between May 12, 2015 and April 20, 2016.
06/10/16 07:09 AMIntrexon to Present at the Jefferies 2016 Healthcare Conference - [at noodls] - GERMANTOWN, Md., June 10, 2016/PRNewswire /-- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announces Geno Germano, President of Intrexon, will present at the Jefferies Healthcare Conference ...
06/09/16 08:00 PMIntrexon Corporation (XON) Drops 7.41% on June 08 - Equities.com
06/09/16 08:00 PMFibrocell Science Inc (NASDAQ:FCSC) & Intrexon Corp (NYSE:XON) Healthcare Trend Analysis Report - Wall Street 24
06/09/16 04:04 PMFINAL NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Intrexon Corporation And Encourages Investors With Losses To Contact The Firm - [Accesswire] - IRVINE, CA / ACCESSWIRE / June 9, 2016 / Khang & Khang LLP (the "Firm") announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company") ...
06/09/16 10:32 AMBad News for Fibrocell’s (FCSC) Clinical-Stage Vocal Chord Therapy
06/09/16 05:42 AM6:42 am Intrexon's Oxitec issues statement regarding the National Academies of Sciences, Engineering, and Medicine recommendations on Gene-drive -
06/08/16 08:00 PMInvestment In Cell And Gene Therapies Ramps Up
06/08/16 04:05 PMOxitec Supports the National Academies of Sciences, Engineering, and Medicine Recommendations on Gene-drive and Highlights Why Oxitec's Self-limiting Approach is the Opposite of Gene-drive Method - [PR Newswire] - Oxitec welcomes the report "Gene Drives on the Horizon", released today by the National Academies of Sciences, Engineering, and Medicine. This report outlines the need for phased testing of gene-drive modified organisms before they can be released into the environment and calls for clearer regulatory oversight of this technology. Oxitec recognises the valuable work being conducted on gene-drive technologies for the use of mosquito control.
06/08/16 01:57 PMThe Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Intrexon Corporation Investors and Encourages Investors to Contact the Firm - [Business Wire] - Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Intrexon Corporation securities between July 21, 2015 and January 13, 2016, inclusive .
06/08/16 10:34 AMINTREXON CORPORATION (NYSE:XON) Financial Condition Compared to S&P 500 - CML News
06/08/16 07:18 AMFibrocell Reports Phase II azficel-T Trial for Treatment of Vocal Cord Scarring Did Not Meet Primary Endpoints - [at noodls] - EXTON, Pa., June 08, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), an autologous cell and gene therapy company focused on developing transformational therapies for diseases affecting ...
06/07/16 11:59 AMJULY 6 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Intrexon Corporation and Advises Investors with Losses to Contact the Firm - [Accesswire] - LOS ANGELES, CA / ACCESSWIRE / June 7, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company") (NYSE: XON) concerning ...
06/07/16 10:19 AMInvestigation for Long-Term Investors in Intrexon Corp (NYSE:XON) over Potential Wrongdoing by Certain Directors ... - Digital Journal
About Intrexon Corp

Intrexon Corp logoIntrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company's synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale. Its technologies combine the principles of precision engineering, statistical modeling, automation and production at an industrial scale. The Company's technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing, or LEAP, and ActoBiotics platform.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: XON
  • CUSIP:
Key Metrics:
  • Previous Close: $24.00
  • 50 Day Moving Average: $26.96
  • 200 Day Moving Average: $30.47
  • P/E Ratio: N/A
  • P/E Growth: 0.29
  • Market Cap: $2.84B
  • Current Quarter EPS Consensus Estimate: $-1.30 EPS
Additional Links:
Intrexon Corp (NYSE:XON) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha